VXI Receives Frost & Sullivan’s 2026 North America Company of the Year for Excellence in Revenue Generating Solutions Leadership
Recognized for innovation, AI-driven sales optimization, and measurable customer success in revenue…
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
January 23, 2026 17:00 ET | Source: Corvus Pharmaceuticals, Inc. SOUTH SAN…
